Subscribe to RSS
DOI: 10.1055/s-2004-830904
Snake Venoms and the Neuromuscular Junction
Publication History
Publication Date:
15 July 2004 (online)

There are ∼420 venomous species of snakes living on the earth. Their venoms, each unique, can affect multiple organ systems. The venoms have a predilection for the peripheral nervous system where the neuromuscular junction is a favorite target. Those venoms affecting the release of acetylcholine from the presynaptic membrane are called β-neurotoxins and those affecting the postsynaptic membrane are called α-neurotoxins. α-Bungarotoxin has been used in quantitative studies of acetylcholine receptor density and turnover and for the assay of antibodies directed against the acetylcholine receptor. A unique feature of timber rattlesnake venom is its ability to cause clinical myokymia. This likely results from a blockade of voltage gated K+ antibodies.
KEYWORDS
Snake neurotoxins - neuromuscular junction - myokymia
REFERENCES
- 1 Dowling H G, Duellman W E. Systematic Herpetology: A Synopsis of Families and Higher Categories. New York; Hiss Publications 1978: 100-102
- 2 White J, Warrell D, Eddleston M, Currie B J, Whyte I M, Isbister G K. Clinical toxinology: where are we now?. J Toxicol Clin Toxicol. 2003; 41 263-276
- 3 Juckett G. Venomous snakebites in the United States: management review and update. Am Fam Physician. 2002; 65 1367-1374
- 4 Gutmann L, Gutmann L. Timber rattlesnake myokymia. J Peripher Nerv Syst. 2003; 8 19
- 5 Parrish H M. Incidence of treated snakebites in the United States. Public Health Rep. 1966; 81 269-276
- 6 Harris J B. Phospholipases in snake venoms and their effects on nerve and muscle. Pharmacol Ther. 1985; 31 79-102
- 7 Lee C Y. Recent advances in chemistry and pharmacology of snake toxins. Adv Cytopharmacol. 1979; 3 1-16
- 8 Cousin X, Bon C. Acetylcholinesterase from snake venom as a model for its nerve and muscle counterpart. J Nat Toxins. 1999; 8 285-294
- 9 Hodgson W C, Wickramaratna J C. In vitro neuromuscular activity of snake venoms. Clin Exp Pharmacol Physiol. 2002; 29 807-814
- 10 Chiappinelli V. Actions of snake venom toxins on neuronal nicotinic receptors and other neuronal receptors. Pharmacol Ther. 1985; 31 1-32
- 11 Conolly S, Trevett A J, Nwokolo N C et al.. Neuromuscular effects of Papuan Taipan snake venom. Ann Neurol. 1995; 38 916-920
- 12 Harris J B. Snake venoms in science and clinical medicine: 3. Neuropharmacological aspects of the activity of snake venoms. Trans R Soc Trop Med Hyg. 1989; 83 745-747
- 13 Atchison W. Effects of neurotoxicants on synaptic transmission: lessons learned from electrophysiological studies. Neurotoxicol Teratol. 1988; 10 393-416
- 14 Harris J B. Polypeptides from snake venoms which act on nerve and muscle. Prog Med Chem. 1984; 21 63-110
- 15 Dixon R, Harris J B. Myotoxic activity of the toxic phospholipase A2, β-bungarotoxin: its clinical significance. Am J Pathol. 1999; 154 447-455
- 16 Fatehi M, Harvey A L, Rowan E G. Characterization of the effects of depolarizing toxins on nerve terminal action potentials: apparent block of presynaptic potassium currents. Toxicon. 1998; 36 115-129
- 17 Harvey A L. Twenty years of dendrotoxins. Toxicon. 2001; 39 15-26
- 18 Simson L L, Lautenslager G T, Kaiser I I, Middlebrook J L. Identification of the site at which the phospholipase A2 neurotoxins act to produce their neuromuscular blocking effects. Toxicon. 1993; 31 13-26
- 19 Su M J, Chang C C. Presynaptic effects of snake venom toxins which have phospholipase A2 activity (β-bungarotoxin, taipoxin, crotoxin). Toxicon. 1984; 22 631-640
- 20 Yang C. Cobrotoxin. Structure and function. J Nat Toxins. 1999; 8 221-233
- 21 Harris J B, Grubb B D, Maltin C A, Dixon R. The neurotoxicity of the venom phospholipases A2, notexin and taipoxin. Exp Neurol. 2000; 161 517-526
- 22 Rugulo M J, Dolly O, Nicholis D G. The mechanism of action of β-bungarotoxin at the presynaptic plasma membrane. Biochem J. 1986; 233 519-523
- 23 Mebs D. Snake venoms. Toolbox of the neurobiologist. Endeavour. 1989; 13 157-161
- 24 Endo T, Tamiya N. Current view on the structure-function relationship of postsynaptic neurotoxins from snake venoms. Pharmacol Ther. 1987; 34 403-451
- 25 Brick J F, Gutmann L, Brick J, Apelgren K N, Riggs J E. Timber rattlesnake venom-induced myokymia: evidence for peripheral nerve origin. Neurology. 1987; 37 1545-1546
- 26 Brick J F, Gutmann L. Rattlesnake venom-induced myokymia. Muscle Nerve. 1982; 5 S98-S100
Robert L LewisM.D.
Department of Neurology, Robert C. Byrd Health Sciences Center, West Virginia University
One Medical Center Drive, Morgantown, WV 26505